185 results on '"de Kreutzenberg, Saula Vigili"'
Search Results
2. MASLD, hepatic steatosis and fibrosis are associated with the prevalence of chronic kidney disease and retinopathy in adults with type 1 diabetes mellitus
Catalog
Books, media, physical & digital resources
3. Association between different modalities of insulin administration and metabolic dysfunction-associated fatty liver disease in adults with type 1 diabetes mellitus
4. Glucose-lowering drugs with cardiovascular benefits as modifiers of critical elements of the human life history
5. Telemedicine for the Clinical Management of Diabetes; Implications and Considerations After COVID-19 Experience
6. MASLD, hepatic steatosis and fibrosis are associated with the prevalence of chronic kidney disease and retinopathy in adults with type 1 diabetes mellitus
7. Association between different modalities of insulin administration and metabolic dysfunction-associated fatty liver disease in adults with type 1 diabetes mellitus
8. Hepatic steatosis with significant fibrosis is associated with an increased 10-year estimated risk of cardiovascular disease in adults with type 1 diabetes mellitus
9. NAD+-dependent SIRT1 deactivation has a key role on ischemia–reperfusion-induced apoptosis
10. Supplemental Materials for Dei Cas A (JCEM 2023) Sex differences in cardiovascular disease and cardiovascular risk estimation in patients with type 1 diabetes
11. The impact of glucose-lowering medications on cardiovascular disease
12. Sex Differences in Cardiovascular Disease and Cardiovascular Risk Estimation in Patients With Type 1 Diabetes.
13. Hypovitaminosis D is associated with erectile dysfunction in type 2 diabetes
14. Characteristics and outcomes of the hyperglycemic hyperosmolar non-ketotic syndrome in a cohort of 51 consecutive cases at a single center
15. Why to screen heart disease in diabetes
16. Elevated white blood cell count is associated with prevalence and development of the metabolic syndrome and its components in the general population
17. The metabolic syndrome influences the response to incretin-based therapies
18. Oxidative stress and vascular disease in diabetes: Is the dichotomization of insulin signaling still valid?
19. Insulin signaling and life span
20. Diabetes causes bone marrow autonomic neuropathy and impairs stem cell mobilization via dysregulated p66Shc and Sirt1
21. Endothelial Progenitor Cells Are Reduced in Acromegalic Patients and Can Be Restored by Treatment With Somatostatin Analogs
22. Additional file 1 of PAR-4/Ca2+-calpain pathway activation stimulates platelet-derived microparticles in hyperglycemic type 2 diabetes
23. The effects of oral amino acid intake on ambulatory capacity in elderly subjects
24. Diabetes impairs stem cell and proangiogenic cell mobilization in humans
25. Downregulation of the Longevity-Associated Protein Sirtuin 1 in Insulin Resistance and Metabolic Syndrome: Potential Biochemical Mechanisms
26. Mechanisms of endothelial dysfunction in obesity
27. Updated Recommendations on Cardiovascular Prevention in 2022: An Executive Document of the Italian Society of Cardiovascular Prevention.
28. Peripheral Blood CD34+KDR+ Endothelial Progenitor Cells Are Determinants of Subclinical Atherosclerosis in a Middle-Aged General Population
29. Circulating CD34+ cells, metabolic syndrome, and cardiovascular risk
30. Insulin generates free radicals in human fibroblasts ex vivo by a protein kinase C-dependent mechanism, which is inhibited by pravastatin
31. Effects of Different Insulin Regimes on Postprandial Myocardial Perfusion Defects in Type 2 Diabetic Patients
32. Acute Alcohol Consumption Improves Insulin Action Without Affecting Insulin Secretion in Type 2 Diabetic Subjects
33. L-Arginine-Nitric Oxide Kinetics in Normal and Type 2 Diabetic Subjects: A Stable-Labelled 15N Arginine Approach
34. [Consensus document and recommendations for the prevention of cardiovascular disease in Italy - 2018]
35. L-arginine-nitric oxide kinetics in normal and type 2 diabetic subjects: a stable-labelled [sup.15]N arginine approach. (Pathophysiology)
36. Effects of Treatment With Sulfonylurea Drugs or Insulin on Ischemia-Induced Myocardial Dysfunction in Type 2 Diabetes
37. Elevated non-esterified fatty acids impair nitric oxide independent vasodilation, in humans: evidence for a role of inwardly rectifying potassium channels
38. Executive Summary of the 2018 Joint Consensus Document on Cardiovascular Disease Prevention in Italy
39. Documento di consenso e raccomandazioni per la prevenzione cardiovascolare in Italia 2018 [Consensus document and recommendations for the prevention of cardiovascular disease in Italy - 2018]
40. Hepatic sensitivity to insulin: effects of sulfonylurea drugs
41. Recommendations for Cardiovascular Prevention During the Sars-Cov-2 Pandemic: An Executive Document by the Board of the Italian Society of Cardiovascular Prevention.
42. Effects of Basal Insulin on Lipid Profile Compared to Other Classes of Antihyperglycemic Agents in Type 2 Diabetic Patients.
43. Circulating levels and characterization of microparticles in patients with different degrees of glucose tolerance
44. Blood expression of matrix metalloproteinases 8 AND 9 and of their inducers S100A8 and S100A9 Supports diagnosis and prognosis of PDAC-associated diabetes mellitus
45. miR-30c-5p regulates macrophage-mediated inflammation and pro-atherosclerosis pathways.
46. Sirtuin 1 stabilization by HuR represses TNF-α- and glucose-induced E-selectin release and endothelial cell adhesivenessin vitro: relevance to human metabolic syndrome
47. The Endothelium Abridges Insulin Resistance to Premature Aging
48. NETosis Delays Diabetic Wound Healing in Mice and Humans.
49. Hemodynamics assessed via approximate entropy analysis of impedance cardiography time series: effect of metabolic syndrome
50. Insulin signaling and life span
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.